IL6 and neoplasm: Upon tumor engagement, CAR T-cell secrete pro-inflammatory cytokines such as GM-CSF and IL-8, which promote the release of the major CRS biomarker IL-6 as well as IL-8, cytokines that were previously shown to be monocyte-dependent (19).